#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small for dates baby Central nervous system neoplasm Renal cell carcinoma Turner's syndrome Rett syndrome Non-Hodgkin's lymphoma refractory T-cell type acute leukaemia Immunoglobulin G4 related disease Mantle cell lymphoma Primary adrenal insufficiency Renal disorder Primary amyloidosis Castleman's disease Hereditary spastic paraplegia Phenylketonuria More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome Toxic epidermal necrolysis Erdheim-Chester disease Combined immunodeficiency – Life with Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Proteus syndrome – Trials in Disease Kearns-Sayre syndrome – Basic Information Langerhans’ cell histiocytosis – Treatment Cystic fibrosis – Diagnostics Progressive supranuclear palsy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Binimetinib Concizumab GSK5458514 Dopamine Hydrochloride Azd8205 Etoposide Phosphate Collagenase Surzebiclimab Valproic Acid Ucp4 Retinol Palmitate Nemtabrutinib ULEFNERSEN Caplacizumab Abbv-668 Cagrilintide Diroximel Fumarate Ly3298176 AZD6234 Tetracycline Hydrochloride More therapies…

    Learn about Your Condition

    Menopausal symptoms Phaeochromocytoma Cervix carcinoma stage II Haemodialysis Embolism Diabetic foot infection Hepatic fibrosis Cervical dysplasia Myeloid leukaemia Lymphoedema Thrombocytosis Antisynthetase syndrome Colorectal adenoma Drug eruption Anogenital dysplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Stopping Prednisolone Early in Patients with Negative FDG-PET/CT and Idiopathic Retroperitoneal Fibrosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Retroperitoneal fibrosis
    Investigated Drugs:
    • Prednisolone
    France

  • Study on Pain Relief Using Serratus Plane Block with Ropivacaine, Lidocaine Hydrochloride, and Dexamethasone Sodium Phosphate for Intensive Care Patients Undergoing Pleural Drainage

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ropivacaine
    • Dexamethasone Sodium Phosphate
    • Lidocaine Hydrochloride
    France

  • Study on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Prednisone
    Belgium Croatia Greece Hungary Italy Poland

  • Study on the Effects of Ketoprofen and Drug Combination in Patients Undergoing Pleurodesis Surgery for Pneumothorax

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pneumothorax
    Investigated Drugs:
    • Nefopam
    • Tramadol
    • Cellulose, Microcrystalline
    France

  • Study on Nefopam for Reducing Postoperative Pain in Adults After Total Knee Replacement Surgery

    Recruiting

    3 1 1
    Investigated Drugs:
    • Morphine Sulfate
    • Nefopam Hydrochloride
    • Morphine Hydrochloride
    France

  • Study of Mirikizumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium France Italy The Netherlands Norway +3
Previous Page
1 … 326 327 328 329 330 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!